US 7,524,935 B2
Sequences characteristic of hypoxia-regulated gene transcription
Paz Einat, Nes Ziona (Israel); Rami Skaliter, Nes Ziona (Israel); Elena Feinstein, Rehovot (Israel); Aviv Regev, Cambridge, Mass. (US); and Hagar Kalinski, Rishon-le-Zion (Israel)
Assigned to Quark Pharmaceuticals, Inc., Fremont, Calif. (US)
Filed on May 25, 2006, as Appl. No. 11/440,016.
Application 11/440016 is a continuation of application No. 09/802472, filed on Mar. 09, 2001, granted, now 7,074,895.
Application 09/802472 is a continuation in part of application No. 09/384096, filed on Aug. 27, 1999, abandoned.
Application 09/384096 is a continuation in part of application No. 09/138109, filed on Aug. 21, 1998, abandoned.
Claims priority of provisional application 60/132684, filed on May 05, 1999.
Claims priority of provisional application 60/098158, filed on Aug. 27, 1998.
Claims priority of provisional application 60/056453, filed on Aug. 21, 1997.
Prior Publication US 2006/0241290 A1, Oct. 26, 2006
Int. Cl. C07K 16/00 (2006.01)
U.S. Cl. 530—387.1 10 Claims
 
1. An isolated molecule which comprises the antigen-binding portion of an antibody specific for a polypeptide consisting of SEQ ID NO:4.